An FDA-Approved Cancer Treatment
Novocure™ has a new FDA-approved weapon (NovoTTF-100A System™) for patients and physicians in the battle against cancer (specifically for treating recurrent brain tumors). Microcurrent therapy is a novel anti-mitotic treatment that has been shown to slow or reverse tumor progression by inducing cell death in certain solid tumors. Their microcurrent device will be available for prescription use in the U.S. initially through several noted brain cancer research centers.
Pulsed electromagnetic field (PEMF) therapy has been used to treat almost every conceivable human illness or malady, including many inflammatory diseases such as arthritis or psoriasis and you don’t have to wait for the FDA to approve this treatment for your kind of cancer. All you have to do is choose among the many options in terms of equipment. (more…)